Key Dates

Related Announcements

RFA-DA-23-049 - HEAL Initiative: Therapeutics Development for Opioid Use Disorder in Patients with Co-occurring Mental Disorders (UG3/UH3 - Clinical Trial Optional)

Issued by

National Institute on Aging (NIA)

Purpose

This Notice informs potential applicants that the National Institute on Aging (NIA) is participating, effective immediately, in Funding Opportunity Announcement (FOA) RFA-DA-23-049, "HEAL Initiative: Therapeutics Development for Opioid Use Disorder in Patients with Co-occurring Mental Disorders (UG3/UH3 - Clinical Trial Optional)."

The following sections of RFA-DA-23-049 have been modified:

Part 1. Overview Information

Components of Participating Organizations

Currently Reads:

National Institute on Drug Abuse (NIDA)

National Institute of Mental Health (NIMH)

National Center for Complementary and Integrative Health (NCCIH)

Modified to Read (changes shown in bold italics):

National Institute on Drug Abuse (NIDA)

National Institute of Mental Health (NIMH)

National Center for Complementary and Integrative Health (NCCIH)

National Institute on Aging (NIA)

Assistance Listing Number(s)

Currently Reads:

93.279, 93.242, 93.213

Modified to Read (changes shown in bold italics):

93.279, 93.242, 93.213, 93.866

Part 2. Full Text of Announcement

Section VII. Agency Contacts

This section was modified to add the following contacts:

Scientific/Research Contact(s)

Devon Oskvig, Ph.D.
National Institute on Aging (NIA)
Phone: 301-827-5899
Email: devon.oskvig@nih.gov

Financial/Grants Management Contact(s)

Jeni Smits
National Institute on Aging (NIA)
Phone: 301-827-4020
Email: jeni.smits@nih.gov

All other aspects of the FOA remain the same.

Inquiries

Please direct all inquiries to:

Devon Oskvig, Ph.D.
National Institute on Aging (NIA)
Phone: 301-827-5899
Email: devon.oskvig@nih.gov